Evidence map›Paper›PMID 38374586›Full record

ArticleACS applied materials & interfaces2024

Ebrahim Sadeghi, Sanaz Chamani, Ipek Deniz Yildirim, Emre Erdem, Naeimeh Sadat Peighambardoust, Umut Aydemir

Open access · hybridAbstract read
In one paragraph

Article in ACS applied materials & interfaces, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 26 citations in OpenAlex.

  1. Multi-Metallic Organic Framework-Based Composites as Electrocatalysts.Small (Weinheim an der Bergstrasse, Germany) · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ebrahim SadeghiKoç University Boron and Advanced Materials Applications and Research Center (KUBAM), Sariyer, Istanbul 34450, Turkey.ORCID 0000-0003-0832-0546
Sanaz ChamaniKoç University Boron and Advanced Materials Applications and Research Center (KUBAM), Sariyer, Istanbul 34450, Turkey.
Ipek Deniz YildirimFaculty of Engineering and Natural Sciences, Materials Science and Nano Engineering, Sabanci University, Istanbul 34956, Turkey.
Emre ErdemFaculty of Engineering and Natural Sciences, Materials Science and Nano Engineering, Sabanci University, Istanbul 34956, Turkey.ORCID 0000-0002-8395-0364
Naeimeh Sadat PeighambardoustKoç University Boron and Advanced Materials Applications and Research Center (KUBAM), Sariyer, Istanbul 34450, Turkey.ORCID 0000-0002-2991-5488
Umut AydemirKoç University Boron and Advanced Materials Applications and Research Center (KUBAM), Sariyer, Istanbul 34450, Turkey.ORCID 0000-0003-1164-1973
Koç University · TRSabancı Üniversitesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hydrogen shows great promise as a carbon-neutral energy carrier that can significantly mitigate global energy challenges, offering a sustainable solution. Exploring catalysts that are highly efficient, cost-effective, and stable for the hydrogen evolution reaction (HER) holds crucial importance. For this, metal-organic framework (MOF) materials have demonstrated extensive applicability as either a heterogeneous catalyst or catalyst precursor. Herein, a nanostructured interface between NiMo/CuO@C derived from Cu-MOF was designed and developed on nickel foam (NF) as a competent HER electrocatalyst in alkaline media. The catalyst exhibited a low overpotential of 85 mV at 10 mA cm

Indexed as

electrocatalysishydrogen evolution reactionmetal−organic frameworknanostructured interfacetransition metal oxides

Identifiers

PMID38374586
PMCPMC10910462
OpenAlexW4391963604

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.